±q¼w°ê¤Þµo­P¦º©Êªº¸z¹D¥X¦å©Ê¤j¸z±ìµß¦¾¬Vªº®£·W©Ê¼sªx©Ê­¹ª«¤¤¬r®×¡A²³æ¤¶²Ð¤j¸z±ìµß

   

¤j¸z±ìµß¬O¸z¤º±ìµß¬ì(Enterobacteriacea)ªºEscherichiaÄÝ¡A¡]¾Ç¦W¡GEscherichia coli¡A³q±`²¼g?E. coli¡^¡A¬O¤H©M°Êª«¸z¹D¤¤³Ì¥D­n©M¼Æ¶q³Ì¦hªº¤@ºØ²Óµß¡A¥D­n±H¥Í©ó¤j¸z¤º¡C¬O¤@ºØ¨âºÝ¶w¶ê¡B¯à¹B°Ê¡BµLªÞÌUªº­Ý©Ê¹½®ñ­²Äõ¤ó³±©Êµu±ìµß¡A¥i¥Í¦s©ó¦³®ñ©ÎµL®ñªºÀô¹Ò¡C°£¬Y¨Çµß«¬¯à¤Þ°_¸¡Âm¥~¡A¤@¯ë¤£­P¯f¡A¯à¦X¦¨ºû¥Í¯ÀB©MK¡A¹ï¤HÅ馳¯q¡C¤j¸z±ìµß¬OÁ{§É¤W³Ì±`¤ÀÂ÷ªº²Óµß¤§¤@¡A¤×¨ä¬Oªc§¿¹D·P¬V»P¿È½H¡A¥D­nªº·P¬V·½¬°¯f¤H¥»¨­ÁT«K¡C¤j¸z±ìµß¬O¸z¤ºªº¥¿±`µßÂO¡A³Q¥Î¨ÓºÊ´ú¤ô½è¬O§_¾D¨üÁT«K¦¾¤ô¦¾¬Vªº«ü¼Ð¡C¨ä¹ê¡A¦h¼Æ¤j¸z±ìµß¹ï©ó¤HÃþ¬OµL®`¡A¬O¸ò¤HÃþ¦@¥Íªº²Óµß¡C¦ý¤´¦³¨Ç¬ðÅܪº¤j¸z±ìµßµß«¬¬O¦³®`¤HÃþªº¡A¥D­n¬O¤Þ°_­¹ª«¤¤¬r¡A³Ì±`µo¥Íªº¯gª¬¬°¸¡Âm¡A¨Ò¦p¡G¥»¦¸³y¦¨¼w°ê¼sªx¬y¦æªºEnterohemorrhagic E. coli (EHEC¡A¸z¹D¥X¦å©Ê¤j¸z±ìµß)¡A°£¤FÃþ¦üµg¯eªº¥X¦å©Ê¸¡Âm¯gª¬¤§¥~¡A©|¥i¤Þ°_µÇŦ°IºÜ¡A¬Æ¦Ü­P¦º¡C¨ä¥Lªº­P¯f©Ê¤j¸z±ìµß¡A¦p¸z¬r¯À«¬¤j¸z±ìµß(enterotoxigeic E. colii; ETEC) ¡B ¸z«Iŧ©Ê¤j¸z±ìµß(enteroinvasive E. coli; EIEC) ¡B ¸z¯f­ì©Ê«¬¤j¸z±ìµß(enteropathogenic E. coli; EPEC) ¡B ¸z¤ºªþµÛ©Ê¤j¸z±ìµß(enteroadherent aggregative E. coli; EAggEC or EAEC)¡A¦³¿³½ìªÌ¡A½Ð¦A°Ñ¾\¥»¤å«áªºªþ¿ý¡C


    ¦¹¦¸ªº¼w°ê¬y¦æªºEHEC¡A¸ò¹L¥hªºO157µß«¬¤£¦P¡A¦ý¯gª¬Ãþ¦ü¡A¥i¥H¤Þ°_­P©Rªº·»¦å©Ê§¿¬r¯g­Ô¸s¡]hemorragic uremic syndrom¡FHUS¡^¡CWHOµo¥¬¡A¦¹¦¸¬y¦æªºµß«¬¬O¥þ·sªºµß«¬¡Aµß«¬¬°O104;H4¡A¦Ó«DO157:H7¡A±a¦³EAECªº¬r©Ê½èÅé¡F¨Ì¾Ú²`¦`µØ¤j°ò¦]¬ã¨s°|¤ñ¹ï©ó1991¦~¨ú±oªºO104;H4ªºµß®è¡A¦¹µß±a¦³EAECªº¯S©Ê¡A¬O¤§«e±q¥¼¦b¥ô¦ó¬Ì±¡¤¤³QÀË´ú¥X¨Ó¡C²Î­p¦Ü5/27¬°¤î¡A¼w°êªº256¨Ò¤ÞµoHUS¯gª¬ªÌ¦³86%¬°¦¨¤H¡A2006 ~ 2010¦~¶¡¦¨¤H¥u¥e1.5%~10%¡CÃĪ«·P¨ü©Ê¸ÕÅ窺µ²ªGÅã¥Ü¬°ESBL¶§©Êªº¤j¸z±ìµß¡C


    EHEC³o­Ó¦Wµü¡A¦­¦b§Ú¥Á°ê70¦~¥N¡A¦b¥x¤¤ºaÁ`·L¥Íª«¬ì²Óµß«ÇªA°È®É¡A½²¤å«°±Ð±ÂªºÁ{§É·L¥Íª«¾Ç¡A¥H¤Î¦³Á{§É·L¥Íª«¬É¸t¸g¤§ºÙªº¬ü°ê·L¥Íª«¾Ç·|¤§Á{§É·L¥Íª«¤â¥U´N¦³¤¶²Ð¦¹µß¡A¨C¦~ªºÂåÀ˾Ƿ|©Î·L¥Íª«¾Ç·|ªº¾Ç³N¬ã°Q·|¡A¸g±`¦³¤Hµoªí¬ÛÃö¬ã¨s¡A©Ò¥HEHEC¹ï©ó±q¨Æ²ÓµßÀËÅ窺ÂåÀË®v¨Ó»¡¨Ã¤£­¯¥Í¡C¦¹µß¨ã¦³O157§Ü¦å²M»PÃþ§Ó¶P¤ó¬r¯À(shiga-like toxin)¡A¨ä¥Í¤ÆŲ©w¯S©Ê¬OµLªkµo»Ã¤s±ù¾J(sorbitol)¡A¥i¥H¸ò¨ä¥L¤j¸z±ìµß°Ï¤À¡C


    ¦¹µß¦­¦Û¦è¤¸1982¦~¦b¬ü°êÃzµo¥X¦å©Êµ²¸zª¢¤§«á¡A³oÃþ«¬¤Þ°_¸¡Âmªº¤j¸z±ìµß¡]E. coli¡^´N¤w³Q½T»{¡A¨ä¦å²M«¬¥D­n¬°O157:H7¡C©Ò¾É­Pªº¸¡Âm¥i¯à¥Ñ»´·Lªº¥¼¥X¦å¨ì¦å«K²{¶H¡A¦Ó¦å«K¤¤¤@¯ëµL¥Õ¦å²yªº¦s¦b¡C±`¦b¬ù¤Q·³¥H¤U¤§¤p«Ä¤Î¦Ñ¦~¤H¤Þ°_¤§¦å«K¸¡Âm¡A¨ä¤¤5¡ã10%¤§¦¹Ãþ¯f¤H·|¤Þ°_·»¦å©Ê§¿¬r¯g­Ô¸s¡]hemolytic uremic syndrome, HUS¡^¤Î®ê¶ë©Ê¦å¤pªO´î¤Ö©Êµµ´³¯g¡]thrombotic thrombocytopenic purpura, TTP¡^¤Î¨ä¥L¦X¨Ö¯g¡C³oÃþ²Óµß·|²£¥Í²Ó­M¬r¯À¡AºÙ¬°Ãþ§Ó¶P¤ó¬r¯À¡]Shiga-like toxins¡^I©MII¡]¦¹«Y¥Ñ©ó¨ä»PS. dysenteriae¤§¬r¯ÀÃþ¦ü¡^¡A¤SºÙverotoxins 1©M2¡A²£¥Í¬r¯Àªº°ò¦]«Y¸g¥Ñ¾½µßÅé±a¤J¤j¸z±ìµß¤¤¡C¦¹µß¤]¨ã¦³¯S²§ªºÅÖ¤ò¡]fimbria¡^¡A¥i¥HªþµÛ©ó¸zÖß½¤¤W¡C


    ¥i¥ÑO157«¬¤j¸z±ìµß¦bMacConkey-sorbitol°ö¾i°ò¤¤µLªkµo»Ãsorbitol(¤s±ù¾J)¡A¥H¤Î¨ä¨ã¦³Ãþ§Ó¶P¤ó¬r¯À¤§¯S©Ê¡A©ÎÂǥѦå²M«¬§O¤§Å²©w¡A©Î¥HDNA±´°w¨ÓÃÒ¹ê¨ä¨ã¦³¬r¯À°ò¦]©Î¬r©Ê½èÅéµ¥¤èªk¨Ó¥[¥H½T©w¡C¤j¦h¼Æ¯f¤H¨S¦³µo¿N¯gª¬¤§²{¶H¡A¬O³oºØ¯e¯f¥i¥H»P±ìµß©Êµg¯e¡B¸z¹D«I¤J©Ê¤j¸z±ìµß©ÎCampylobacterµ¥µßºØ©Ò¤Þ°_ªº¤Uµg°Ï¤À¤§³B¡C
¥H¤W¸ê®Æ¦³°Ñ¦Ò(¸Ô²Ó¸ê®Æ¥i¥H¤Wºô¾\Ū)¡G
1.ºû°ò¦Ê¬ì¡Ghttp://zh.wikipedia.org/wiki/%E5%A4%A7%E8%85%B8%E6%A1%BF%E8%8F%8C
2.¹Å¸q¿¤½Ã¥Í§½ºô¸ô½Ã±Ð¸ê®Æ¡Ghttp://www.cichb.gov.tw/disease/dise1-6.htm

¤U·s»D¬O2011.06.06ºK¿ý¦Û¤j³°ªº¤¤°ê·s»Dºô¡A½Ð°Ñ¾\¡G
 ¼w­P¦º¤j¸z±ìµß¯f·½ªì¨BÂê©w¬°¨§ªÞ¤u¼t¤wÃö³¬
2011¦~06¤ë06¤é03:42   ¨Ó·½¡G ¤¤°ê·s»Dºô   §@ªÌ¡G ¶ÀÁ÷¬õ
¤¤·sªÀ¬fªL6¤ë5¤é¹q(°OªÌ¶ÀÁ÷¬õ)¼w°ê¤UÂħJ´Ë¦{¹A·~³¡ªøªL¼w°Ò5¤é±ß¥l¶}·s»Dµo¥¬·|«Å¥¬,²£¦Û¸Ó¦{ªº¨§ªÞ³Qªì¨B»{©w¬°ªñ¨Ó¼w°ê¤j­±¿n¶Ç¬Vªº¸z¥X¦å©Ê¤j¸z±ìµßEHEC¯f·½¡C ¥Í²£³o¨Ç±aµß¨§ªÞªº¤u¼t¥Ø«e¤w³QÃö³¬,«Ý¦¸¤é¹êÅç«ÇÀËÅçµ²ªG´¦¾å«á¦A¦æ³B²z¡C
ªL¼w°ÒºÙ,¦ì©ó¤UÂħJ´Ë«\º¸§Â(Uelzen)¦a°Ïªº¤@®a¥ø·~¥Í²£18ºØªÞÃþ½­µæ,¥Í²£¹Lµ{¤¤ºØ¤l³Q©ñ¦b¤@­Óºuµ©¤¤,¸g¼QÅx38«×ªº¼ö¤ô«áºØ¤lµoªÞ,³o­Ó·Å«×¦P¼Ë¾A¦X¨ä¥¦µßÃþªº¥Íªø¡CªL¼w°Ò»¡,³o¨ÇªÞÃþ¦b¥Íªø¹Lµ{¤¤¨S¦³¨Ï¥ÎªÎ®Æ,«Ü¥i¯à¬OµoªÞ¥Îªº¤ô²£¥Í¤F¦Ã¬V,©ÎªÌ¬OºØ¤l¨Æ¥ýªg¬V²Óµß,¦bµoªÞªºÀô¹Ò¤¤¨³³tÁc´Þ¡C
¸Ó¥ø·~ªº²£«~³Q³\¦hÀ\ÆU¥Î§@¨F©Ô­ì®Æ¡C½Õ¬dµ²ªGªí©ú,³\¦h¯f¤H¦b¤£¦PÀ\ÆU­¹¥Î¤F§t¦³¸Ó¥ø·~¥Í²£ªº¨§ªÞ¨F©Ô¤§«á±w¯f¡C¨Ã¥B¸Ó¥ø·~¥ç¦³¨â¦W¤u§@¤H­û·P¬V¸¡Âm,¨ä¤¤¤@¦W³QÃÒ¹ê·P¬V¸z¥X¦å©Ê¤j¸z±ìµß¡C
¥Ñ©ó¥Ø«eÁÙ¨S¦³±o¨ì¹êÅç«Çªº·Ç½T¼Æ¾Ú,Áp¨¹°·±d³¡¨S¦³ÃÒ¹ê³o¤@µ²ªG¡C ­t³d¬y¦æ¯f¹w¨¾¤ÎºÊ·þªºÃ¹§B¯S-¦Ò»®¾Ç°|»{¬°,¦b¯f·½¨S¦³¤Q¤À½T©wªº±¡ªp¤U,«Øij¥Á²³Ä~Äò©ñ±ó¥Í¦Y½­µæ¡C
¦Û¤­¤ëªì¼w°ê¥X²{¤j­±¿nEHEC¯fµß¶Ç¬V¤§«á,¸Ó¯fµß­º¥ý¦b¦è¯Z¤ú¶i¤f¶À¥Ê¤W³Qµo²{,«á³Q¹êÅç«ÇÃÒ¹ê¶À¥Ê¤W¯fµß©M­P¯f¯fµß¨Ã«D¦P¤@¤ä¡C ¥Ø«e¼w°ê¤wª¾¸z¥X¦å©Ê¤j¸z±ìµß±wªÌªñ2¤d¤H,20¦º¤`,627¤H·P¬V¤W¨Ãµo¯g¦å·»©Ê§¿¬r¯g¡C
ªÞÃþ½­µæ´¿¸g¦³¦h¦¸­P¯f¥ý¨Ò¡C 1996¦~,¤p¬õÅÚ½³ªÞ´¿¸g¦b¤é¥»¤Þ°_¤@³õÄY­«ªº¸z¹D¶Ç¬V¯f¡C ·í®É·P¬V¤j¸z±ìµßªº±wªÌ¦³12600¾l¤H,¦ý¥u¹ï¤Ö¼Æ¤H³y¦¨¦å·»©Ê§¿¬r¯g³o¼Ëªº­P©R¨Ãµo¯g¡C

ªþ¿ý¡G­P¯fªº¤j¸z±ìµß²¤¶¦p¤U¡G(½Ð°Ñ¾\http://tw.knowledge.yahoo.com/question/question?qid=1007042000927)
¥Ø«e¤w¸g­q¥XO:H¦å²M«¬§O¬ù¦³200ºØ¥H¤W¡ALevine µ¥¤H¨Ì¾Ú¸¡Âm«¬¤j¸z±ìµßªº­P¯f¯S©Ê¤Îµo¯f«¬ºAÂk¯Ç¡A¥D­n¦³¤»¤jÃþ¡G
(1) ¸z¬r¯À«¬¤j¸z±ìµß(enterotoxigeic E. colii; ETEC)
(2) ¸z«Iŧ©Ê¤j¸z±ìµß(enteroinvasive E. coli; EIEC) :
(3) ¸z¯f­ì©Ê«¬¤j¸z±ìµß(enteropathogenic E. coli; EPEC) :
(4) ¸z¤ºªþµÛ©Ê¤j¸z±ìµß(enteroadherent aggregative E. coli; EAggEC or EAEC)
(5) ´Ï®§©Ê¤j¸z±ìµß("attaching and effacing" E. coli)¡G°Ñ¾\(3)EPEC
(6) ¸z¹D¥X¦å©Ê¤j¸z±ìµß(enterohemorrageic E. coli; EHEC)¡G¬°¥»¦¸¤Þ°_¼Ú¬w¡A¤×¨ä¬O¼w°êªº¨§ªÞ¥Íµæ­¹ª«¤¤¬rªº¬y¦æµß®è¡C

²³æ¤¶²Ð¤W­z¤»Ãþ­P¯f©ÊE. coli¦p¤U¡G

(1)ETEC : ¤Þ°_¸¡Âm¤§¥D­n­ì¦]¬°¦¹µß¤Àªc¼ö­@¨ü©Ê¸z¬r¯À¤Î¼ö±Ó·P©Ê¸z¬r¯À§@¥Î©ó¤p¸z²Ó­M¡A¨ë¿E²Ó­M¤º  adenylate cyclase©Îguanylate cyclase¼W¥[¡A¶i¦Ó¨ÏÅé²G¬y¥¢³y¦¨¤ô¼Ë«K¡C¥Ø«e¥Î¨Ó¤À¿ëETECªº¯S¼x°£¤FLT I¤ÎSTa¥~ÁÙ¦³¡GO¦å²M«¬¡]Lipopolysacchride¡^¡BH¦å²M«¬¡]flagella¡^¤ÎCFA¡]colonization factor antigens¡^

(2)EIEC:¦¹Ãþ«¬¤j¸z±ìµßªº¥Í¤Æ¯S©Ê¡B°ò¦]¯S©Ê¤Î­P¯f«¬ºA»PShigella spp.·¥¬°¬Û¦ü¡C¥Ñ¬ã¨s³ø§iÅã¥Ü¡A¦h¼Æ¬y¦æ©Ê·P¬V¥Ñ­¹ª«©Î¤ô³y¦¨¡AÂA¤Ö¥Ñ¤H¶Ç¤Hªº¤è¦¡¤¬¬Û¶Ç¬V¡CÁ{§É¯S¼x¬°¤ô¼Ë©Ê¸¡Âm¡A¦ý¦³¤Ö³¡¥÷ÄY­«¯f¤H·|¦³Ãþ¦üµg¯eªº²{¶H¡]¦å«K¡BÁT«K¤¤¥X²{ÂH½¤²Ó­M¤Î¥Õ¦å²y¡^¡C¨ä­P¯f¦]¤l°ò¦]¦ì©ó½èÅépInv¤Î¬V¦âÅé¤W¡A­P¯f°ò¦]²£ª«­t³d«I¤J¤Î½Õ¸`¯}Ãa¤j¸z¤W¥Ö²Ó­M¡A¨Ã¦b²Ó­M¤ºÁc´Þ¡A¦A«I¤J¾Fªñ¨ä¥¦¤W¥Ö²Ó­M¡A³y¦¨¯}Ãa©Ê²Ó­Mµoª¢¤ÏÀ³¡C¶Ç²ÎÀË´úEIEC¥HSereny¸ÕÅç¤ÎHela²Ó­M¬r©Ê¸ÕÅç¨ÓŲ§O¡A¥Ø«e¤w¦³¬ã¨s§Q¥Îprobe hybridization©ÎPCR°»´úial°ò¦]§@¬°§Ö³tŲ§Oªº¤è¦¡¡C

(3)EPEC : ±`µo¥Í©ó®L¤Ñ¤Î¤p©ó2·³À¦¨à«Äµ£¡C¦¹µß­P¯fªº¥D­n¯S¼x¬°¦b¨ü·P¬VªÌ¤p¸z²Õ´¤Á¤ù¤¤¥iµo²{¤@A/E¡]attaching and effacing¡^(5)³¡¦ì¡AªþµÛ¸z²Ó­M¤WµßÅ骺intimate»P¤p¸zµ³¤ò§Î¦¨ªº¤@°Ï¶ô¡A¥iª½±µ¦b¹q¤lÅã·LÃè¤UÆ[¹î¨ì©Î¥H¿Ã¥ú¬V¦â¤è¦¡Æ[¹î¡C¦¹Ãþµßªº­P¯f¾÷¨î¤À¦¨¤T¶¥¬q¡A(A)Localized adherence¡G60MDa ¡]EAF, EPEC adherence factor¡^½èÅ餧²£ª«½Õ¸`BFP (bundle-forming pilus)ªþµÛ©ó¤p¸zÂH½¤¤W¥Ö²Ó­M¡F¡]B¡^Signal transduction¡Geae¤Î¨ä¥L°ò¦]³Q¬¡¤Æ¨Ã¯}Ãa·Lµ³¤òµ²ºc¡F¡]C¡^Intimate adherene¡G²ÓµßÂÇ¥ÑintiminªþµÛ¦Ü¤p¸z¤W¥Ö²Ó­M¡A¨Ã¯}Ãa¤p¸zÂH½¤§Î¦¨A/E³¡¦ì¤Þ°_¤ô¼Ëª¬¸¡Âm¡A©óÁT«K¤¤¥iµo²{ÂH½¤²Ó­M¡C

(4)EAggEC or EAEC¡G¦bCraviotoµ¥¤H°µEPEC¤§HEp-2²Ó­MªþµÛ©Ê¸ÕÅç¹Lµ{¤¤­º¦¸µo²{¡A¬ã¨sÅã¥Ü¿ë»{EAggEC¤è¦¡¬°¡G¥Í¤Æ¤ÏÀ³¬°E. coli¡A¤£¤ÀªcST©ÎLT¸z¬r¯À¡A¨Ã¥B¥HAA¡]Aggregative adherence¡^§ÎºAªþµÛ©óHEp-2²Ó­M¤W¡CÁ{§É¤W¯f¤H¦³68%·|«ùÄò©Ê¸¡Âm¡]? 14¤Ñ¡^¡A¨Ã¥B¦h¼Æ¬°À¦¨à¡A¦³¹Ã¦RµLµo¿N²{¶H¡C¦¹¦¸¤Þ°_¼w°êªºO104:H4 EHEC´N±a¦³EAEC±o¬r©Ê½èÅé¡A¥i¥H

(6)EHEC¡G¯f¤H·|¥X²{ÄY­«¸¡µ±µh¡B¤ô¼Ëª¬¸¡Âm±µÄòÂH¸Yª¬¦å«K¡B»´·L©ÎµLµo¿N¯gª¬¡A¥B³¡¤À¡]10%¥H¤U¡^¯f¤H¦]¨ÖµoÄY­«ªºµÇ°IºÜ¡B·»¦å©Ê§¿¬r¯g­Ô¸s¡]hemorragic uremic syndrom¡FHUS¡^¤Î¦å®ê©Ê¦å¤pªO¯Ê¥F©Êµµ´³¯g¡]thrombotic thrombocytopenic purpura¡FTTP¡^¦Ó¦º¤`¡C¥D­n­P¯f¾÷ÂରµßÅéªþµÛ©ó¤p¸zÂH½¤¡A¨ÃÄÀ©ñVero¬r¯À¡]¤À¬°VT I¤ÎVT II¡A¤SºÙ¬°SLT I¤ÎSLT II¡^¨Ï¤p¸z²Ó­M¨ü·l¡A¤Þ°_¥X¦å±¡§Î¡C¥Ø«e¬ã¨s¾ÇªÌ¦h»{¬°Vero¬r¯À¬°¨ä¥D­n­P¯f¦]¤l¡AÀË´ú¤èªk¥D­n¥HRPLA©ÎELISA¤èªk´úÀË¥Xµß¬O§_¤Àªc¬r¯À¡A©Î¥HPCR¤è¦¡´úvt I¤Îvt II°ò¦]¡A¤ÎO157:H7«¬¤j¸z±ìµß¯S®í¯Ê³´°ò¦]uidA¡C¤j¸z±ìµß·|µo»Ãsorbitol¡A¦ÓE. coli O157¡GH7¨Ã¤£µo»Ã¡A¦bsorbitol MacConkey°ö¾i°ò¤W§e²{µL¦âµß¸¨¡A¦]¦¹¦¹ºØ°ö¾i°ò¥i§@¬°¤ÀÂ÷VTECªº¿ï¾Ü©Ê°ö¾i°ò¡CEHEC O157:H7ÁöµM¦³uidA°ò¦]¡A¦ý¨ä°ò¦]²£ª«£]-¸²µå¿}îÇ»Äúê¯Ê¬¡©Ê¡AµLªk¤À¸Ñ4-¥Ò°ò³Ê§Îà¬-£]-D-¸²µå¿}îǻġ]MUG¡^²£¥Í¿Ã¥ú¡A§YMUG³±©Ê¡C¶·ª`·Nªº¬O¡A¼w°ê¦¹¦¸¬y¦æªºµß«¬¬O¥þ·sªºµß«¬¡Aµß«¬¬°O104:H4¡A¦Ó«DO157:H7¡A¤§«e±q¥¼¦b¥ô¦ó¬Ì±¡¤¤³QÀË´ú¥X¨Ó¡C
Shigatoxin 1: - (negative), Shigatoxin 2 (vtx2a): + (positive), Intimin (eae): - (negative), Enterohemolysin: - (negative)
EaggEC Virulence plasmid:  -   aatA-PCR: + (positive),  -   aggR-PCR: + (positive),  -   aap-PCR: + (positive)

¸ê®Æ¨Ó¦Û¡G
http://tw.knowledge.yahoo.com/question/question?qid=1007042000927
http://www.bioscience.ws/encyclopedia/index.php?title=2011_E._coli_O104:H4_outbreak
http://www.marlerblog.com/case-news/pulsed-field-gel-electrophoresis-pattern-of-e-coli-o104h4-in-german-outbreak/